Skip to main content
. 2017 Jul 29;28(9):2225–2232. doi: 10.1093/annonc/mdx285

Figure 3.

Figure 3.

Breast cancer-free interval (BCFI) for women aged <40 years (A) and ≥40 years (B) at diagnosis, according to timing of triptorelin initiation with chemotherapy, from the landmark time point beginning 1 year after the final dose of adjuvant chemotherapy.